Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
暂无分享,去创建一个
D. Podzamczer | H. Stellbrink | A. Rieger | M. Cavassini | F. Post | G. Moyle | M. Fisher | P. Domingo | T. Branco | C. Vavro | A. Norden | Michael L. Lim | N. Givens | M. Khuong-Josses | Helen Pearce